Pure Global

"Kabi" Louvre Cell Treatment Kit - Taiwan Registration 76749791b38f1c2349f043d38f8da8a6

Access comprehensive regulatory information for "Kabi" Louvre Cell Treatment Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 76749791b38f1c2349f043d38f8da8a6 and manufactured by Fresenius Kabi AG;; Fenwal International, Inc.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
76749791b38f1c2349f043d38f8da8a6
Registration Details
Taiwan FDA Registration: 76749791b38f1c2349f043d38f8da8a6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Kabi" Louvre Cell Treatment Kit
TW: โ€œๅกๆฏ”โ€ ็พ…ๆตฎ็ดฐ่ƒž่™•็†ๅฅ—็ต„
Risk Class 2

Registration Details

76749791b38f1c2349f043d38f8da8a6

DHA05603439603

Company Information

Dominican Republic;;Germany

Product Details

This product is a single-use kit for the separation and preparation of blood components.

B Hematology, pathology, and genetics

B.9245 Automated hemocytoseparator

Input;; QMS/QSD

Dates and Status

Apr 19, 2021

Apr 19, 2026